Epidemiology and Antifungal Susceptibility Profiling of Clinical Isolates From a Community Acquired Tinea Imbricata Outbreak Among the Bateq Subtribe in Pahang, Malaysia
Main Article Content
Abstract
Introduction: Tinea imbricata (TI) outbreak poses a significant health burden among indigenous populations in rainforest regions due to their geographical isolation and poor socioeconomic conditions. This study aimed to investigate the epidemiological trends, antifungal susceptibility patterns, and treatment outcomes of TI among the Bateq subtribe in Pahang, Malaysia. Materials and Methods: A cross-sectional survey was conducted between July–October 2023 in five villages within the National Rainforest Park, Malaysia. Socio-demographic characteristics, clinical manifestations, and treatment outcomes were collected through interviews, laboratory investigations, and clinical examinations. Treatment modalities were evaluated for their effectiveness in reducing disease burden. Results: 569 individuals were surveyed, revealing a TI prevalence rate of 7.91% with children aged 15 years and below exhibiting the highest susceptibility (9.22%). Antifungal susceptibility testing of clinical isolates of Trichophyton concentricum demonstrated high sensitivity to terbinafine (GM MIC=0.144 μg/ml, GM MFC=0.198 μg/ml, p<0.05) and griseofulvin (GM MIC=1.741 μg/ml, GM MFC=4.782 μg/ml, p<0.05), while clotrimazole showed moderate activity (GM MIC=5.897 μg/ml, GM MFC=22.291 μg/ml). Fluconazole demonstrated the least potency, with no fungicidal activity observed at concentrations up to 128 μg/ml. Treatment outcomes indicated that combination therapy (terbinafine gel and oral griseofulvin) significantly outperformed terbinafine gel alone, achieving an almost complete lesion resolution (LA reduced to 0.158±0.158 cm² versus 3.684±1.522 cm², p<0.05). Conclusion: These findings provide critical insights into the epidemiology and emerging drug resistant of TI in the Bateq subtribe, highlighting the importance of continued surveillance, monitoring, and adaptation of treatment strategies to combat evolving antifungal resistance patterns.
Downloads
Article Details
References
Leung AKC, Leong KF, Lam JM. Tinea Imbricata. Journal of Pediatrics. 2018;200: 285-285.e1. https://doi.org/10.1016/j.jpeds.2018.04.012.
Henley D. Hygiene, housing and health in colonial Sulawesi. In: van Dijk, C. (Kees) ; Taylor JG (ed.) Cleanliness and Culture: Indonesian Histories. Verhandelingen van het Koninklijk Instituut voor Taal-, Land- en Volkenkunde; 2013. p. 95–116. https://doi.org/10.1163/9789004253612_005.
Er YX, Lee SC, Than LTL, Muslim A, Leong KF, Kwan Z, et al. Tinea Imbricata among the Indigenous Communities: Current Global Epidemiology and Research Gaps Associated with Host Genetics and Skin Microbiota. Journal of Fungi. 2022;8(2): 1–21. https://doi.org/10.3390/jof8020202.
Pihet M, Bourgeois H, Mazière JY, Berlioz-Arthaud A, Bouchara JP, Chabasse D. Isolation of Trichophyton concentricum from chronic cutaneous lesions in patients from the Solomon Islands. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2008;102(4): 389–393. https://doi.org/10.1016/j.trstmh.2008.01.002.
Salari S, Ayatollahi Mousavi SA, Hadizadeh S, Izadi A. Epidemiology of dermatomycoses in Kerman province, southeast of Iran: A 10-years retrospective study (2004–2014). Microbial Pathogenesis. 2017;110: 561–567. https://doi.org/10.1016/j.micpath.2017.07.043.
Valari M, Stathi A, Petropoulou T, Kakourou T, Pangali A, Arabatzis M. Cases of Tinea capitis due to pale isolates of Trichophyton violaceum (Trichophyton glabrum) in South-East Europe. A challenge to the clinical laboratory. Medical Mycology Case Reports. 2012;1(1): 66–68. https://doi.org/10.1016/j.mmcr.2012.08.003.
King ME, Bensyl DM, Goodman RA, Rasmussen SA. Conducting a Field Investigation. In: Rasmussen SA, Goodman RA (eds.) The CDC Field Epidemiology Manual. 5th ed. Centers for Disease Control and Prevention (CDC); 2019. p. 33–52. https://doi.org/10.1093/oso/9780190933692.003.0003.
Er YX, Than LTL, Muslim A, Yap NJ, Tee MZ, Abdull-Majid N, et al. Infection patterns of scabies and tinea between inland and resettled indigenous Negrito communities in Peninsular Malaysia. PLoS neglected tropical diseases. 2024;18(9): e0012515. https://doi.org/10.1371/journal.pntd.0012515.
Zahari BJ. Batek tribe told to seek immediate treatment for fungal infection. New Straits Times. 2019.: 1. https://www.nst.com.my/news/nation/2019/03/474765/batek-tribe-told-seek-immediate-treatment-fungal-infection
Ibrahim R. Penduduk Kampung Aring 5 pula dijangkiti penyakit kulit. Metro. 2019.: 1. https://www.hmetro.com.my/mutakhir/2019/04/442332/penduduk-kampung-aring-5-pula-dijangkiti-penyakit-kulit
Ng KP, Soo-Hoo TS, Na SL, Ang LS. Dermatophytes isolated from patients in University Hospital, Kuala Lumpur, Malaysia. Mycopathologia. 2003;155(4): 203–206. https://doi.org/10.1023/A:1021194025765.
Roslan SR, Hadi AA. A child with unique skin pattern: A case report of Tinea imbricata. Medical Journal of Malaysia. 2022;77(1): 113–115. https://www.e-mjm.org/2022/v77n1/tinea-imbricata.pdf
Sharma B, Nonzom S. Superficial mycoses, a matter of concern: Global and Indian scenario-an updated analysis. Mycoses. 2021;64(8): 890–908. https://doi.org/doi.org/10.1111/myc.13264.
Gaurav V, Bhattacharya SN, Sharma N, Datt S, Kumar P, Rai G, et al. Terbinafine resistance in dermatophytes: Time to revisit alternate antifungal therapy. Journal of Medical Mycology. 2021;31(1). https://doi.org/10.1016/j.mycmed.2020.101087.
Sardana K, Sharath S, Khurana A, Ghosh S. An update on the myriad antifungal resistance mechanisms in dermatophytes and the place of experimental and existential therapeutic agents for Trichophyton complex implicated in tinea corporis and cruris. Expert review of anti-infective therapy. 2023;21(9): 977–991. https://doi.org/10.1080/14787210.2023.2250555.
Nahar D, Mohite P, Lonkar A, Chidrawar VR, Dodiya R, Uddin MJ, et al. An insight into new strategies and targets to combat antifungal resistance: A comprehensive review. European Journal of Medicinal Chemistry Reports. 2024;10: 100120. https://doi.org/10.1016/j.ejmcr.2023.100120.
Jia S, Long X, Hu W, Zhu J, Jiang Y, Ahmed S, et al. The epidemic of the multiresistant dermatophyte Trichophyton indotineae has reached China. Frontiers in Immunology. 2023;13(February): 1–14. https://doi.org/10.3389/fimmu.2022.1113065.
Singh Gill J, Chatterjee M, Baveja S, Hazra N, Tandel K, R V, et al. Clinical study on antifungal drug resistance among cases of dermatophytosis in patients reporting to multiple tertiary care hospitals. Medical Journal Armed Forces India. 2023;79: S244–S249. https://doi.org/10.1016/j.mjafi.2023.01.002.
Mustaffa MF, Ramasamy K, Jaafar N, Hasan MH, Ramli NA, Suratman S, et al. In-situ film-forming solution for topical application of terbinafine hcl: Biopharmaceutical evaluation and in vivo antifungal performance using animal model. International Journal of Applied Pharmaceutics. 2021;13(6): 98–105. https://doi.org/10.22159/ijap.2021v13i6.42589.
MeteoAtlas. Taman Negara National Park (Malaysia) - Climate Summary and Historical Weather Data. Meteo Atlas website. p. 47666. https://meteoatlas.com/malaysia/taman-negara-national-park-47666
Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. CLSI Standard M38, 3rd Ed. 2018;28(14): 0–13.
Mustaffa MF, Raman WANA, Husain N, Hamid HA. Hydrogen Sulphide Ameliorates the Toxic Effect of Clotrimazole Against Trichophyton rubrum. Malaysian Journal of Medicine and Health Sciences. 2023;19: 59–64. https://doi.org/10.47836/mjmhs.19.5.10.
Awaad A, Olama ZA, El-Subruiti GM, Ali SM. The dual activity of CaONPs as a cancer treatment substance and at the same time resistance to harmful microbes. Scientific Reports. 2023;13(1). https://doi.org/10.1038/s41598-023-49637-6.
Hakimi NES, Zaini AZ, Mustaffa MF. Antimicrobial Prospects of Domesticated Ornamental Leaf Extracts Against Skin Pathogens. Indonesian Journal of Pharmacy. 2025;36(1): 116–128. https://doi.org/10.22146/ijp.15057.
Sivasankar S, Boppe A, Grobusch MP, Jeyaraj S. Evaluation of MMV Pandemic Response Box compounds to identify potent compounds against clinically relevant bacterial and fungal clinical isolates in vitro. New Microbes and New Infections. 2024;60–61. https://doi.org/10.1016/j.nmni.2024.101444.
Muslim A, Aazmi S, Er YX, Shahrizal S, Lim YAL. Ascaris lumbricoides harbors a distinct gut microbiota profile from its human host: Preliminary insights. Food and Waterborne Parasitology. 2024;34(November 2023): e00223. https://doi.org/10.1016/j.fawpar.2024.e00223.
Esposto MC, Lazzarini C, Prigitano A, Olivi A, Monti M, Tortorano AM. Trichophyton concentricum in skin lesions in children from the Salomon Islands. Giornale Italiano di Dermatologia e Venereologia. 2015;150(5): 491–494. https://www.minervamedica.it/en/journals/Ital-J-Dermatol-Venereol/article.php?cod=R23Y2015N05A0491
Adna EF, Aruan RR. Tinea Imbrikata pada Dua Saudara Kandung. Cermin Dunia Kedokteran. 2022;49(11): 624–628. https://doi.org/10.55175/cdk.v49i11.317.
Panti-May JA, Zonta ML, Cociancic P, Barrientos-Medina RC, Machain-Williams C, Robles MR, et al. Occurrence of intestinal parasites in Mayan children from Yucatán, Mexico. Acta Tropica. 2019;195(October 2018): 58–61. https://doi.org/10.1016/j.actatropica.2019.04.023.
Norrenberg S, Monod M, Christen-Zaech S. Outbreak of Trichophyton soudanense causing tinea capitis in an orphanage in Myanmar. Journal of Medical Mycology. 2020;30(4): 101013. https://doi.org/10.1016/j.mycmed.2020.101013.
Leung AKC, Leong KF, Lam JM. Tinea Imbricata: An Overview. Current Pediatric Reviews. 2019;15(3): 170–174. https://doi.org/10.2174/1573396315666190207151941.
U. Budimulja, K. Kuswadji, S. Bramono, J. Basuki, L. Judanarso, S. Untung, S. widagdo, Rhprabowo Wydianto, D. Koesanto PW. A double‐blind, randomized, stratified controlled study of the treatment of tinea imbricata with oral terbinafine or itraconazole. British Journal of Dermatology. 1994;130(s43): 29–31. https://doi.org/10.1111/j.1365-2133.1994.tb06091.x.
Bagra JK, Nair SS, Athira V, Suman Kumar M, Kumar M, Thomas P, et al. In vitro virulotyping, antifungal susceptibility testing and DNA fingerprinting of Microsporum canis strains of canine and feline origin. Comparative Immunology, Microbiology and Infectious Diseases. 2024;104(November 2023): 102100. https://doi.org/10.1016/j.cimid.2023.102100.
Allahdadi M, Hajihossein R, Kord M, Rahmati E, Amanloo S, Didehdar M. Molecular characterization and antifungal susceptibility profile of dermatophytes isolated from scalp dermatophyte carriage in primary school children in Arak city, Center of Iran. Journal de Mycologie Medicale. 2019;29(1): 19–23. https://doi.org/10.1016/j.mycmed.2019.01.002.
Koehler A, Ribeiro AC, Pagani DM, Vettorato R, Magagnin CM, Stopiglia CDO, et al. Molecular identification and antifungal susceptibility of 75 clinical isolates of Trichophyton spp. from southern Brazil. Journal of Medical Mycology. 2021;31(4). https://doi.org/10.1016/j.mycmed.2021.101201.
Hay R. Therapy of skin, hair and nail fungal infections. Journal of Fungi. 2018. https://doi.org/10.3390/jof4030099.
El Attar Y, Atef Shams Eldeen M, Wahid RM, Alakad R. Efficacy of topical vs combined oral and topical antifungals in white piedra of the scalp. Journal of Cosmetic Dermatology. 2021;20(6): 1900–1905. https://doi.org/10.1111/jocd.13769.
Mahajan S, Tilak R, Kaushal SK, Mishra RN, Pandey SS. Clinico-mycological study of dermatophytic infections and their sensitivity to antifungal drugs in a tertiary care center. Indian Journal of Dermatology, Venereology and Leprology. 2017;83(4): 436–440. https://doi.org/10.4103/ijdvl.IJDVL_519_16.
Selviana, Budastutik I, Linda Suwarni M. Trichophyton concentricum as a cause of tinea imbricata. Journal of Pakistan Association of Dermatologists. 2019;29(2): 165–169. https://jpad.com.pk/index.php/jpad/article/view/1258